Solid organ transplantation in AL amyloidosis

American Journal of Transplantation

Volumn 10, Issue 9, 2010, Pages 2124-2131

  Sattianayagam, P T ^a   Gibbs, S D J ^a   Pinney, J H ^a   Wechalekar, A D ^a   Lachmann, H J ^a   Whelan, C J ^a   Gilbertson, J A ^a   Hawkins, P N ^a   Gillmore, J D ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

AL amyloidosis; amyloid; amyloidosis; heart transplantation; kidney transplantation; liver transplantation

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ADULT; AGED; AMYLOIDOSIS; ARTICLE; CARDIAC GRAFT REJECTION; CHEMOTHERAPY; CLINICAL ARTICLE; FEMALE; GRAFT FAILURE; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MEDICAL ASSESSMENT; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION; SURVIVAL RATE;

ADULT; AGED; AMYLOIDOSIS; DEATH, SUDDEN, CARDIAC; FEASIBILITY STUDIES; HEART TRANSPLANTATION; HUMANS; KAPLAN-MEIERS ESTIMATE; KIDNEY TRANSPLANTATION; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; RECURRENCE; STEM CELL TRANSPLANTATION; TREATMENT OUTCOME;

EID: 77956149714     PISSN: 16006135     EISSN: 16006143     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2010.03227.x     Document Type: Article

References (29)

1. Kyle RA, Linos A, Beard CM et al. Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood 1992 79 : 1817 1822.
2. Kyle RA, Gertz MA. Primary systemic amyloidosis: Clinical and laboratory features in 474 cases. Semin Hematol 1995 32 : 45 59.
3. Gertz MA, Leung N, Lacy MQ et al. Clinical outcome of immunoglobulin light chain amyloidosis affecting the kidney. Nephrol Dial Transplant 2009 24 : 3132 3137.
4. Selvanayagam JB, Hawkins PN, Paul B, Myerson SG, Neubauer S. Evaluation and management of the cardiac amyloidosis. J Am Coll Cardiol 2007 50 : 2101 2110.
5. Dubrey SW, Cha K, Anderson J et al. The clinical features of immunoglobulin light-chain (AL) amyloidosis with heart involvement. QJ Med 1998 91 : 141 157.
6. Gastineau DA, Gertz MA, Rosen CB, Kyle RA. Computed tomography for diagnosis of hepatic rupture in primary systemic amyloidosis. Am J Hematol 1991 37 : 194 196.
7. 123I serum amyloid P component scintigraphy in 484 patients. Gut 1998 42 : 727 734.
8. Park MA, Mueller PS, Kyle RA, Larson DR, Plevak MF, Gertz MA. Primary (AL) hepatic amyloidosis: Clinical features and natural history in 98 patients. Medicine (Baltimore) 2003 82 : 291 298.
9. Merlini G, Palladini G. Amyloidosis: Is a cure possible? Ann Oncol 2008 19 (Suppl 4 63 68.
10. Hosenpud JD, DeMarco T, Frazier OH et al. Progression of systemic disease and reduced long-term survival in patients with cardiac amyloidosis undergoing heart transplantation. Circulation 1991 84 (Suppl III 338 343.
11. Lachmann HJ, Booth DR, Booth SE et al. Misdiagnosis of hereditary amyloidosis as AL (primary) amyloidosis. N Engl J Med 2002 346 : 1786 1791.
12. 123I-labeled serum amyloid P component. N Engl J Med 1990 323 : 508 513.
13. Gertz MA, Comenzo R, Falk RH et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis. Am J Hematol 2005 79 : 319 328.
14. Wechalekar AD, Hawkins PN, Gillmore JD. Perspectives in treatment of AL amyloidosis. Br J Haematol 2008 140 : 365 377.
15. Hartmann A, Holdaas H, Fauchald P et al. Fifteen years' experience with renal transplantation in systemic amyloidosis. Transpl Int 1992 5 : 15 18.
16. Kyle RA, Gertz MA, Greipp PR, Witzig TE, Lust JA, Lacy MQ. A trial of three regimens for primary amyloidosis: Colchicine alone, melphalan and prednisone, and melphalan, prednisone, and colchicine. N Engl J Med 1997 336 : 1202 1207.
17. Lachmann HJ, Gallimore R, Gillmore JD et al. Outcome in systemic AL amyloidosis in relation to changes in concentration of circulating free immunoglobulin light chains following chemotherapy. Br J Haematol 2003 122 : 78 84.
18. Sherif AM, Refaie AF, Sobh MA et al. Long-term outcome of live donor kidney transplantation for renal amyloidosis. Am J Kidney Dis 2003 42 : 370 375.
19. Emiroglu R, Basaran O, Pehlivan S et al. Effect of amyloidosis on long-term survival in kidney transplantation. Transplant Proc 2005 37 : 2967 2968.
20. Casserly LF, Fadia A, Sanchorawala V et al. High-dose intravenous melphalan with autologous stem cell transplantation in AL amyloidosis-associated end-stage renal disease. Kidney Int 2003 63 : 1051 1057.
21. Leung N, Griffin MD, Dispenzieri A et al. Living donor kidney and autologous stem cell transplantation for primary systemic amyloidosis (AL) with predominant renal involvement. Am J Transplant 2005 5 : 1660 1670.
22. Nowak G, Westermark P, Wernerson A et al. Liver transplantation as rescue treatment in a patient with primary AL kappa amyloidosis. Transpl Int 2000 13 : 92 97.
23. Roberts MS, Angus DC, Bryce CL, Valenta Z, Weissfeld L. Survival after liver transplantation in the United States: A disease-specific analysis of the UNOS database. Liver Transpl 2004 10 : 886 897.
24. Dispenzieri A, Gertz M, Kyle R et al. Serum cardiac troponins and N-terminal pro-brain natriuretic peptide: A staging system for primary systemic amyloidosis. J Clin Oncol 2004 22 : 3751 3757.
25. Everly MJ. Cardiac transplantation in the United States: An analysis of the UNOS registry. Clin Transpl 2008 : 35 43.
26. Gillmore JD, Goodman HJ, Lachmann HJ et al. Sequential heart and autologous stem cell transplantation for systemic AL amyloidosis. Blood 2006 107 : 1227 1229.
27. Lacy MQ, Dispenzieri A, Hayman SR et al. Autologous stem cell transplant after heart transplant for light chain (Al) amyloid cardiomyopathy. J Heart Lung Transplant 2008 27 : 823 829.
28. Kristen AV, Sacks FU, Schonland SO et al. Staged heart transplantation and chemotherapy as a treatment option in patients with severe cardiac light-chain amyloidosis. Eur J Heart Fail 2009 11 : 1014 1020.
29. Mignot A, Bridoux F, Thierry A et al. Successful heart transplantation following melphalan plus dexamethasone therapy in systemic AL amyloidosis. Haematologica 2008 93 : e32 e35.